.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,795,721

« Back to Dashboard

Details for Patent: 5,795,721

Title: High affinity nucleic acid ligands of ICP4
Abstract:Methods are described for the identification and preparation of high-affinity nucleic acid ligands to Transcripion Regulatory Factors, specifically ICP4. Included in the invention are specific ssDNA and RNA ligands to ICP4 identified by the SELEX method.
Inventor(s): Rabin; Ross S. (Boulder, CO), Jayasena; Sumedha D. (Boulder, CO), Gold; Larry (Boulder, CO)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:Jan 25, 1996
Application Number:08/591,989
Claims:1. A method of identifying nucleic acid ligands to an ICP4 protein family member, comprising:

a) preparing a candidate mixture of nucleic acids;

b) contacting the candidate mixture of nucleic acids with an ICP4 protein family member, wherein nucleic acids having an increased affinity to an ICP4 protein family member relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;

c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and

d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding an ICP4 protein family member, wherein nucleic acid ligands of an ICP4 protein family member may be identified.

2. The method of claim 1 further comprising:

e) repeating steps b), c), and d).

3. The method of claim 1 wherein the ICP4 protein family member is ICP4.

4. The method of claim 1 wherein said candidate mixture of nucleic acids is comprised of single stranded nucleic acids.

5. The method of claim 1 wherein said candidate mixture of nucleic acids is comprised of single stranded ribonucleic acids.

6. The method of claim 1 wherein said candidate mixture of nucleic acids is comprised of single stranded deoxyribonucleic acids.

7. The method of claim 1 wherein said candidate mixture of nucleic acids is comprised of double stranded nucleic acids.

8. A purified and isolated non-naturally occurring nucleic acid ligand to a Transcription Regulatory Factor identified according to the method of claim 1.

9. A purified and isolated non-naturally occurring nucleic acid ligand to ICP4.

10. The nucleic acid ligand to ICP4 of claim 10 identified according to the method of claim 1.

11. The nucleic acid ligand to ICP4 of claim 10 identified according to the method of claim 2.

12. The nucleic acid ligand of claim 10, wherein said ligand is ssDNA selected from the group consisting of the sequences set forth in Tables 5 and 7-8 (SEQ ID NOS:17-57, 59-74).

13. The nucleic acid ligand of claim 10, wherein said ligand is an RNA selected from the group consisting of the sequences set forth in Table 9 (SEQ ID NOS:75-86).
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc